Richard E. Sampliner

Active 1970–2020

72
Papers
23,168
Citations
71
h-index
72
i10-index

Citations

Citations per year for Richard E. Sampliner1971: 2 citations1972: 5 citations1973: 6 citations1975: 1 citations1976: 1 citations1977: 4 citations1978: 3 citations1979: 1 citations1980: 1 citations1981: 5 citations1982: 3 citations1983: 2 citations1984: 7 citations1985: 5 citations1986: 7 citations1987: 7 citations1988: 5 citations1989: 14 citations1990: 15 citations1991: 29 citations1992: 36 citations1993: 47 citations1994: 56 citations1995: 58 citations1996: 62 citations1997: 74 citations1998: 95 citations1999: 123 citations2000: 145 citations2001: 167 citations2002: 193 citations2003: 201 citations2004: 234 citations2005: 236 citations2006: 237 citations2007: 206 citations2008: 231 citations2009: 210 citations2010: 185 citations2011: 150 citations2012: 155 citations2013: 176 citations2014: 130 citations2015: 121 citations2016: 122 citations2017: 76 citations2018: 56 citations2019: 226 citations2020: 176 citations2021: 150 citations2022: 91 citations2023: 68 citations2024: 142 citations2025: 52 citations2026: 1 citations1974: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,892 citing papers, 38.8% of this breakdownUnited Kingdom: 423 citing papers, 8.7% of this breakdownNetherlands: 236 citing papers, 4.8% of this breakdownGermany: 232 citing papers, 4.8% of this breakdownItaly: 196 citing papers, 4% of this breakdownJapan: 177 citing papers, 3.6% of this breakdownCanada: 158 citing papers, 3.3% of this breakdownAustralia: 157 citing papers, 3.2% of this breakdownChina: 153 citing papers, 3.1% of this breakdownFrance: 144 citing papers, 3% of this breakdownSpain: 83 citing papers, 1.7% of this breakdownSweden: 79 citing papers, 1.6% of this breakdown
0%38.8%Other 19.4%

Fields

  • Medicine90.1%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Nursing1.4%
  • Immunology and Microbiology0.6%
  • Engineering0.5%
  • Agricultural and Biological Sciences0.4%
  • Other1.8%

Topics

  • Esophageal Cancer Research and Treatment10.4%
  • Colorectal Cancer Screening and Detection7.6%
  • Gastroesophageal reflux and treatments6.6%
  • Hepatitis C virus research6.4%
  • Gastric Cancer Management and Outcomes6%
  • Esophageal and GI Pathology5.6%
  • Other57.4%

Coauthors

All papers

Open in search
  1. Radiofrequency Ablation in Barrett's Esophagus with Dysplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ryan D. Madanick, Amitabh Chak, Charles J. Lightdale - New England Journal of Medicine 2009 cited by 1,437

  2. Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,822

  3. Development and Validation of a Model to Determine Risk of Progression of Barrett’s Esophagus to Neoplasia

    Authors: , , , , , , , , , , , , , , , , , , - Gastroenterology 2017 cited by 136

  4. A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2009 cited by 223

  5. Dysplasia and Cancer in a Large Multicenter Cohort of Patients With Barrett’s Esophagus

    Authors: , , , , , - Clinical Gastroenterology and Hepatology 2006 cited by 404

  6. Association Between Length of Barrett's Esophagus and Risk of High-grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia

    Authors: , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2013 cited by 141

  7. Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. Hawes, Brenda J. Hoffman, Prateek Sharma, Amitabh Chak, Charles J. Lightdale - Gastroenterology 2011 cited by 455

  8. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus

    Authors: , , , , , , , , , , , , , - Gut 2006 cited by 248

  9. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 81

  10. Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease

    Authors: , , , , , , , , , , , , - JAMA 2001 cited by 912

  11. Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John R. Goldblum, Charles A. Gordon, Heike I. Grabsch, Chris Haigh, Michio Hongo, David Johnston, Ricky Forbes–Young, Elaine W. Kay, Philip Kaye, Toni Lerut, Laurence Lovat, Lars Lundell, Philip Mairs, Tadakuza Shimoda, Stuart J. Spechler, Stephen J. Sontag, Peter Malfertheiner, Iain Murray, Manoj Nanji, David Poller, Krish Ragunath, Jarosław Reguła, Renzo Cestari, Neil A. Shepherd, Rajvinder Singh, H. J. Stein, Nicholas J. Talley, Jean–Paul Galmiche, Tony Tham, Peter Watson, Lisa Yerian, Massimo Rugge, Thomas W. Rice, John Hart, Stuart Gittens, David Hewin, J Hochberger, Peter Kahrilas, Sean Preston, Richard E. Sampliner, Prateek Sharma, Robert K. Stuart, Kenneth T. Wang, Irving Waxman, Chris Abley, Duncan E. Loft, Ian Penman, Nicholas J. Shaheen, Amitabh Chak, Gareth Davies, Lorna Dunn, Yngve Falck–Ytter, John de Caestecker, Pradeep Bhandari, Christian Ell, S M Griffin, Stephen Attwood, Hugh Barr, Jeffrey C. Allen, Mark K. Ferguson, Paul Moayyedi, Janusz Jankowski - Gastroenterology 2012 cited by 378

  12. Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis

    Authors: , , , , , - Annals of Internal Medicine 2003 cited by 366

  13. Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary W. Falk, Blair A. Jobe, Robert H. Hawes, Brenda J. Hoffman, Prateek Sharma, Amitabh Chak - Gastroenterology 2017 cited by 124

  14. The difference in colon polyp size before and after removal

    Authors: , , , , - Gastrointestinal Endoscopy 1996 cited by 106

  15. One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 584

  16. Clinical and Economic Assessment of the Omeprazole Test in Patients With Symptoms Suggestive of Gastroesophageal Reflux Disease

    Authors: , , , , , , - Archives of Internal Medicine 1999 cited by 202

  17. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

    Authors: , - The American Journal of Gastroenterology 2008 cited by 2,025

  18. Lack of Effect of a High-Fiber Cereal Supplement on the Recurrence of Colorectal Adenomas

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 828

  19. Practice Guidelines on the Diagnosis, Surveillance, and Therapy of Barrett's Esophagus

    Authors: - The American Journal of Gastroenterology 1998 cited by 801

  20. Five-Year Colon Surveillance After Screening Colonoscopy

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2007 cited by 406

  21. Gallbladder Disease in Pima Indians

    Authors: , , , , - New England Journal of Medicine 1970 cited by 392

  22. Adenoma characteristics as risk factors for recurrence of advanced adenomas

    Authors: , , , , , - Gastroenterology 2001 cited by 265

  23. Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies

    Authors: , , , , , , , , , - The American Journal of Gastroenterology 2007 cited by 237

  24. Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2010 cited by 233